Skip to main navigation Skip to search Skip to main content

A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis

  • John de Kruif
  • , Alexander B. H. Bakker
  • , Wilfred E. Marissen
  • , R. Arjen Kramer
  • , Mark Throsby
  • , Charles E. Rupprecht
  • , Jaap Goudsmit

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

The currently recommended treatment for individuals exposed to rabies virus is the combined administration of rabies vaccine and rabies immune globulin (RIG). This review sets out the criteria used to guide development of a cocktail of human monoclonal antibodies as a replacement for RIG. Using this process as a model, the general requirements for development of safe and efficacious monoclonal antibody alternatives to currently used polyclonal serum products are discussed
Original languageEnglish
Pages (from-to)359-368
JournalAnnual review of medicine
Volume58
DOIs
Publication statusPublished - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis'. Together they form a unique fingerprint.

Cite this